November 29 , 2021
1087 days
630
- ITC is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.
- It is developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru.
- The company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals.
Post Views:
630